tbuckley/cabot-search huggingface dataset:
<i>STAG2</i> Somatic Mutations Are Associated with Specific Dysplastic Megakaryocytic and Myeloid Cell Features in Myelodysplastic Syndrome
Authors: Waihay J Wong, Rebecca L. Zon, Caleb Ho, Olga Pozdnyakova, Donna S. Neuberg, Elisabeth M Battinelli, Marlise R. Luskin, Zuzana Tothova, Elizabeth A. Morgan, Christopher James Gibson, Benjamin L. Ebert
Journal: Blood (2023)
Ruxolitinib in Patients With Chronic Graft-Versus-Host Disease: 3-Year Final Analysis of Efficacy and Safety From the Phase III REACH3 Study
Authors: Robert Zeiser, Domenico Russo, Ron Ram, Shahrukh K Hashmi, Ronjon Chakraverty, Jan Moritz Middeke, Maurizio Musso, Sebastian Giebel, Ant Uzay, Peter Langmuir, Nada Hamad, Xuechan Li, Maanasa Gowda, Tommaso Stefanelli, Stephanie J. Lee, Takanori Teshima, Franco Locatelli
Journal: Blood (2023)
Intracytoplasmatic BCMA Point Mutation and Teclistamab Resistance: Genomic Assessment of a Multidrug-Resistant Multiple Myeloma Patient
Authors: Natalia Buenache Cuenda, Hipolito Nicolas Cuesta Hernández, Alicia Giménez Sánchez, Laura Carneros Blanco, Juan Manuel Rosa-Rosa, Yanira Ruiz-Heredia, Enrique Revilla, Seungbin Han, Umair Munawar, Inmaculada Rapado, Rosa Ayala, K. Martin Kortüm, Antonio Valeri, Santiago Barrio, Joaquin Martinez Lopez, Larissa Haertle
Journal: Blood (2023)
Multiomic Single-Cell Analysis Identifies Von Willebrand Factor and TIM3-Expressing <i>BCR-ABL1</i> + Chronic Myeloid Leukemia Stem Cells
Authors: Malin S. Nilsson, Hana Komic, Johan Gustafsson, Zahra Sheybani, Sanchari Paul, Ola Rolfson, Kristoffer Hellstrand, Lovisa Wennström, Anna Martner, Fredrik B. Thorén
Journal: Blood (2023)
Outcomes after Hematopoietic Cell Transplantation for T-Lineage Acute Lymphoblastic Leukemia and Lymphoma: A Cooperative Study from the Adult Acute Lymphoblastic Leukemia Working Group and the Adult Malignant Lymphoma Working Group of the Japanese Society for Transplantation and Cellular Therapy
Authors: Yuho Najima, Shinichi Kako, Takayoshi Tachibana, Ritsuro Suzuki, Takahito Kawata, Akihito Nagata, Noriko Doki, Takahiro Fukuda, Naoyuki Uchida, Tetsuya Nishida, Mineo Kurokawa, Keisuke Kataoka, Yoshinobu Kanda, Masashi Sawa, Kazuhiro Ikegame, Yuta Katayama, Junji Tanaka, Tatsuo Ichinohe, Yoshiko Atsuta, Eisei Kondo, Yasuyuki Arai
Journal: Blood (2023)
Galloylated Polyphenols Represent a New Class of Antithrombotic Antagonists of Thiol Isomerases
Authors: Moua Yang, Quinn Kennedy, Anika Patel, Da-Yuan Chen, Christina Scartelli, Soravis Osataphan, Roelof Bekendam, Huanzhang Xie, Lin Lin, Alec A Schmaier, Mohsan Saeed, Robert Flaumenhaft
Journal: Blood (2023)
Rituximab and Lenalidomide (R 2) Vs Rituximab Alone As Maintenance Treatment after Chemoimmunotherapy for Elderly Patients with Relapsed/Refractory Follicular Lymphoma (FL): Final Analysis of Renoir Phase III Study of the Fondazione Italiana Linfomi (FIL)
Authors: Carola Boccomini, Barbara Botto, Andrea Evangelista, Vittorio Ruggero Zilioli, Antonella Anastasia, Federica Cavallo, Francesco Merli, Manuela Zanni, Monica Tani, Annalisa Chiarenza, Anna Marina Liberati, Annarita Conconi, Paolo Corradini, Alessia Bari, Giorgia Annechini, Gianluca Gaidano, Michele Spina, Roberto Sartori, Claudia Castellino, Benedetta Puccini, Annalisa Arcari, Sara Bigliardi, Giorgia Matta, Michele Merli, Donato Mannina, Dario Marino, Piero Galieni, Fabrizio Ciambelli, Gerardo Musuraca, Chiara Bottelli, Cristina Muzi, Simone Ferrero, Stefano Luminari, Marco Ladetto, Giovannino Ciccone, Umberto Vitolo
Journal: Blood (2023)
Systematic Prediction of Minor Histocompatibility Antigens to Inform GvHD Outcomes after Allogeneic Stem Cell Transplantation
Authors: Nicoletta Cieri, Nidhi Hookeri, Kari Stromhaug, Liang Li, Julia Keating, Jonathan Stevens, Kameron Kooshesh, Helen Ji, Gabrielle M. Hernandez, Jennifer Abelin, Susan Klaeger, Cleo Forman, Karl Clauser, Siranush Sarkizova, Giacomo Oliveira, Livius Penter, Haesook T. Kim, William Lane, Shuqiang Li, Kenneth J. Livak, Steven A. Carr, Derin B. Keskin, Vincent T. Ho, Jerome Ritz, Robert J. Soiffer, Donna S. Neuberg, Chip Stewart, Gad Getz, Catherine J Wu
Journal: Blood (2023)
The Use of Authorized Concealment to Minimize Nocebo Side Effects: A Survey of US Public Attitudes
Authors: Andrew L Geers, Emily K Spotts, Michael Vang, Samantha R Mayer, Franklin G Miller
Journal: Psychotherapy and Psychosomatics (2023)

&lt;b&gt;&lt;i&gt;Introduction:&lt;/i&gt;&lt;/b&gt; To minimize nocebo effects, it may be possible to employ authorized concealment, in which clinicians tell patients about the nocebo phenomenon and ask if they would prefer not to be informed about mild treatment side effects. &lt;b&gt;&lt;i&gt;Objective:&lt;/i&gt;&lt;/b&gt; The objective of the study was to understand public evaluations of authorized concealment for reducing nocebo effects. &lt;b&gt;&lt;i&gt;Methods:&lt;/i&gt;&lt;/b&gt; An online cross-sectional survey was completed by a demographically diverse US national community sample between June 2 and 6, 2023. Participants were 1,012 adults residing in 48 states, ages ranging from 18 to 94 (mean = 43.2), 65.4% regularly taking medication, and 66.6% reporting a chronic physical or mental health condition. After learning about nocebo effects, participants rated and estimated their likelihood of consenting to four potential methods for authorized concealment of mild side effects. The four methods were ranked for preference and ranked again with the options of (1) receiving all side-effect information and (2) having the opportunity to select among disclosure methods. &lt;b&gt;&lt;i&gt;Results:&lt;/i&gt;&lt;/b&gt; A majority of participants (86.2%) positively endorsed at least one authorized concealment method and 88.2% estimated they would consent to at least one method. Authorized concealment in which individuals learned only the most common side effects or had side-effect information available online received more positive ratings and rankings. A final ranking yielded preferences for receiving all side-effect information (30.4%) and having the opportunity to select side-effect disclosure method (31.8%). &lt;b&gt;&lt;i&gt;Conclusions:&lt;/i&gt;&lt;/b&gt; Our study suggests that many in the public could be open to authorized concealment for mild side effects when it is explained in reference to nocebo effects.
Results from the Cohort-Expansion Stage of a Phase I Trial of Tinostamustine Monotherapy in Advanced Hodgkin Lymphoma (HL), Non-Hodgkin Lymphoma (NHL) and Multiple Myeloma (MM) (NCT02576496)
Authors: Anna Maria Sureda Balari, Herve Ghesquieres, Franck Morschhauser, Pim Mutsaers, Enrique M Ocio, Tomas Janik, Nick Manamley, Kasia Hilgier, Pier Luigi Zinzani
Journal: Blood (2023)
Differential Chromatin Organization between t(4;14) and Non-t(4;14) Multiple Myeloma Driven By the Histone Methyltransferase NSD2
Authors: Chad C. Bjorklund, Junfei Zhao, Gaurav Jain, Natasha Shtraizent, Maria Ortiz, Sambuddo Mukherjee, Patrick R Hagner, Anita K. Gandhi
Journal: Blood (2023)
Impact of “Cell-of-Origin” on Outcome after Axicabtagene-Ciloleucel CAR-T Cell Therapy in Relapsed/Refractory Aggressive Non-Hodgkin B-Cell Lymphomas
Authors: Ilaria Romano, Jordan Gauthier, Ryan C Lynch, Ajay K Gopal, Alexandre V Hirayama, Kikkeri N Naresh, Alireza Torabi, Stephen D Smith, Brian G Till, David G Maloney, Chaitra S Ujjani, Christina Poh, Filippo Milano, Aude G Chapuis, Mazyar Shadman, Lorenzo Iovino
Journal: Blood (2023)
A Phase I Clinical Trial of CLL-1 CAR-T Cells for the Treatment of Relapsed/Refractory Acute Myeloid Leukemia in Adults
Authors: Xiaomei Zhang, Hairong Lv, Xia Xiao, Xue Bai, Pengjiang Liu, Yedi Pu, Juanxia Meng, Haibo Zhu, Zhao Wang, Huan Zhang, Yu Zhang, Cuicui Lv, Li Ma, Ting Yuan, Meng Zhang, Rui Sun, Yifan Zhao, Xinping Cao, Ruiting Guo, Yi Zhang, Shujing Guo, Jile Liu, Mingfeng Zhao
Journal: Blood (2023)
Risk Stratification of Patients with <i>RUNX1-</i>mutated Acute Myeloid Leukemia
Authors: Christian Rausch, Roman Hornung, Aarif M. N. Batcha, Maja Rothenberg-Thurley, Stefanos A. Bamopoulos, Vindi Jurinovic, Bianka Ksienzyk, Stephanie Schneider, Annika Maria Dufour, Michaela Neusser, Maria Cristina Sauerland, Dennis Görlich, Utz Krug, Wolfgang E. Berdel, Bernhard J. Woermann, Jan Braess, Wolfgang Hiddemann, Manja Meggendorfer, Wolfgang Kern, Torsten Haferlach, Johannes Schetelig, Moritz Middeke, Sebastian Stasik, Katharina Egger-Heidrich, Christoph Röllig, Martin Bornhäuser, Christian Thiede, Claudia D Baldus, Carsten Müller-Tidow, Uwe Platzbecker, Hubert Serve, Wendy Stock, Geoffrey L Uy, John C. Byrd, Deedra Nicolet, Ann-Kathrin Eisfeld, Ulrich Mansmann, Karsten Spiekermann, Klaus H Metzeler, Tobias Herold
Journal: Blood (2023)
Nivolumab in Lymphomatoid Granulomatosis (LYG) and Other Epstein-Barr Virus (EBV)-Positive Lymphoproliferative Disorders (LPDs) and Non-Hodgkin Lymphomas (NHLs) with Systemic and/or CNS Involvement: Preliminary Analysis of Efficacy and Safety from an Ongoing Phase II Study
Authors: Disha Dalela, Rahul Lakhotia, Stefania Pittaluga, Jagan R. Muppidi, James D Phelan, Amynah Pradhan, Sarah Evans, Candis Morrison, Atekelt Tadese, Seth M. Steinberg, Jeffrey Cohen, Elaine S. Jaffe, Wyndham H Wilson, Mark Roschewski, Christopher Melani
Journal: Blood (2023)
Mixed Phenotypic Acute Leukemia -Clinical Presentation, Prognosis and Outcomes of Patients Treated with Acute Lymphoblastic Leukemia like Protocols a Multi-Institutional Study from India
Authors: Santhosh Kumar Devadas, Venkatesh Kapu, Lingaraj Nayak, Bhausaheb Bagal, Prashant Tembhare, Aby Abraham, Rajan Kapoor, Jina Bhattacharyya, Parathan Karunakaran, Smitha Carol Saldanha, Smita Kayal, Sharat Damodar, Punit Jain, Om Prakash, Mobin Paul, J John Samuel, Prasanna Samuel
Journal: Blood (2023)
An Assessment of Marrow-Infiltrating T Cells in Early Relapsed Hematologic Cancer Patients Post Allogeneic Hematopoietic Stem Cell Transplantation
Authors: Thi Thuy Duong Pham, Su-Young Choi, Bu-yean Heo, Myung-Won Lee, Jung-Hyun Park, Yunseon Jang, Deog-Yeon Jo, Jaeyul Kwon, Ik Chan Song, Jeong Suk Koh
Journal: Blood (2023)
Minimal Residual Disease (MRD) Status Predicts Outcomes in Patients with Follicular Lymphoma (FL) Treated with Chemo-Immunotherapy on SWOG S0016
Authors: Alexey Danilov, Hongli Li, Mazyar Shadman, Lisa M. Rimsza, Ahmad Zebari, Sonali M. Smith, Michael Leblanc, Jonathan W. Friedberg, Christopher Carlson, Joo Y Song
Journal: Blood (2023)
Efficacy and Safety of Luspatercept in Patients with HbE/β-Thalassemia from the BELIEVE Study: A Subgroup Analysis
Authors: Kevin H.M. Kuo, Pranee Sutcharitchan, Ping Chong Bee, Lee Ping Chew, Soo Min Lim, Ai Sim Goh, Sadanand Vodala, Wen-Ling Kuo, Yinzhi Lai, Loyse Felber Medlin, Martina Perin, Luciana Moro Bueno, Thomas D Coates, Vip Viprakasit
Journal: Blood (2023)
Use of Geriatric Assessment and Genetic Profiling to Personalize Selection of Intensive Versus Low Intensity Chemotherapy in Older Adults with Acute Myeloid Leukemia (AML): Final Results of a Phase II Trial
Authors: Vijaya Raj Bhatt, Christopher Wichman, Thuy T Koll, Alfred Fisher, Tanya M. Wildes, Michael Haddadin, Ann Berger, James Olen Armitage, Sarah A. Holstein, Lori Maness, Krishna Gundabolu
Journal: Blood (2023)
Phase 1 Study of BXCL701, a Dipeptidyl Peptidase Inhibitor, in Relapsed/Refractory Acute Myeloid Leukemia and High-Risk Myelodysplastic Syndrome
Authors: Eric S. Winer, Jacqueline S. Garcia, Richard M Stone, Martha Wadleigh, Marlise R. Luskin, Maximilian Stahl, Evan C. Chen, Rebecca Leonard, Alexis Noyes, Ilene Galinsky, Rashmi Deshpande, Pascal Borderies, Vincent O'Neill, Daniel J. DeAngelo
Journal: Blood (2023)
Affinity Matured CD72 CAR-T Improves Efficacy Versus Low Antigen Density B-Cell Non-Hodgkin Lymphoma Models
Authors: Adila Izgutdina, William C Temple, Matthew Andrew Nix, Huimin Geng, Emilio Ramos, Akul Naik, Rebecca Larson, Fernando Salangsang, Paul Phojanakong, Juan Antonio Camara Serrano, Ons Zakraoui, Isa Tariq, Marcela V Maus, Veronica Steri, Arun P Wiita
Journal: Blood (2023)
Dynamic Frailty Assessment in Transplant Non-Eligible Newly Diagnosed Myeloma Patients: Initial Data from UK Myeloma Research Alliance (UK-MRA) Myeloma XIV (FiTNEss): A Frailty-Adjusted Therapy Study
Authors: Gordon Cook, Charlotte Pawlyn, Kara-Louise Royle, Ethan R Senior, Dax Everritt, Jenny Bird, Stella J. Bowcock, Bryony Dawkins, Mark Drayson, Sharon Gillson, Catherine Olivier, Alan Chant, Matthew W. Jenner, John Robert Jones, Martin F. Kaiser, Bhuvan Kishore, David Meads, Neil Rabin, Roger Owen, Ruth M de Tute, Christopher Parrish, David Allan Cairns, Graham Jackson
Journal: Blood (2023)
Single Cell RNA Sequencing of Sequential Samples before and after BCMA-Directed CAR-T Reveal Features Associated with Non-Durable Response, Exhausted T-Cells and Decreased Expression of Genes Encoding Key Surface Targets in Particular in Patients with Extramedullary Disease
Authors: Ciara Louise L. Freeman, Xiaohong Zhao, Mark B Meads, Jerald Noble, Raghunandan Reddy Alugubelli, Rafael Renatino-Canevarolo, Oliver Hampton, Praneeth Reddy Sudalagunta, Ariosto Siqueira Silva, Rachid Baz, Melissa Alsina, Doris K. Hansen, Xiaofei Song, Kenneth H. Shain
Journal: Blood (2023)
Development and Validation of an Individualized and Weighted Prognostic Model in Patients with Newly Diagnosed Multiple Myeloma
Authors: Wenqiang Yan, Xuehan Mao, David E. Mery, Yan Xu, Weiwei Sui, Shuhui Deng, Dehui Zou, John D Shaughnessy, Jr, Kenneth C. Anderson, Fenghuang Zhan, Lugui Qiu, Gang An
Journal: Blood (2023)
Results of an Italian Retrospective Clinical Experience on Mediastinal Gray Zone Lymphoma
Authors: Luca Nassi, Giovanni Martino, Barbara Botto, Marco Paulli, Riccardo Bruna, Marianna Palazzo, Alice Parisi, Luigi Petrucci, Alberto Fabbri, Monica Balzarotti, Ombretta Annibali, Simone Ragaini, Alessandro Re, Guido Gini, Benedetta Sordi, Antonio Cuneo, Renato Fanin, Claudio Agostinelli, Sabino Ciavarella, Elena Sabattini
Journal: Blood (2023)
Surgical Procedures and Hemostatic Outcome in Patients with Hemophilia Receiving Concizumab Prophylaxis during the Phase 3 explorer7 and explorer8 Trials
Authors: Anthony KC Chan, Chris Barnes, Mary Mathias, Silvia Linari, Francisco Jose Lopez Jaime, Lone Hvitfeldt Poulsen, Julien Bovet, Jan Odgaard-Jensen, Tadashi Matsushita
Journal: Blood (2023)
Cooperative Somatic Alterations in XPO1 and <i>TNFAIP3</i> (A20) Promote Immune Modulation and Tissue Infiltration in Primary Mediastinal B Cell Lymphoma
Authors: Ethan C. Whipp, Janek S. Walker, Mehdi Gharghabi, Casey Cempre, Brandi Walker, Rosa Lapalombella
Journal: Blood (2023)
Tracking of Leukemia and Immune Single Cell Phenotypes during Ipilimumab-Based Treatment By Long-Read Sequencing
Authors: Livius Penter, Mehdi Borji, Adi Nagler, Haoxiang Lyu, Wesley S Lu, Nicoletta Cieri, Alexandria Maurer, Giacomo Oliveira, Aziz M. Al'Khafaji, Kiran Garimella, Shuqiang Li, Donna S. Neuberg, Jerome Ritz, Robert J. Soiffer, Jacqueline S. Garcia, Kenneth J. Livak, Catherine J Wu
Journal: Blood (2023)
Indirect Comparison of Efficacy of Zanubrutinib Versus Orelabrutinib in Patients with Relapsed or Refractory Mantle Cell Lymphoma (R/R MCL): An Updated Analysis with Long-Term Follow up
Authors: Yuqin Song, Keshu Zhou, Dengju Li, Jianda Hu, Dehui Zou, Sujun Gao, Haiyan Yang, Huilai Zhang, Jie Ji, Wei Xu, Ru Feng, Jie Jin, Fangfang Lyu, Cheng Fang, Sheng Xu, Jun Zhu
Journal: Blood (2023)
Revumenib Monotherapy in Patients with Relapsed/Refractory <i>KMT2Ar</i> Acute Leukemias: Efficacy and Safety Results from the Augment-101 Phase 1/2 Study
Authors: Ibrahim Aldoss, Ghayas C. Issa, Michael J Thirman, John DiPersio, Martha Arellano, James S. Blachly, Gabriel Mannis, Alexander Perl, David Dickens, Christine M. McMahon, Elie Traer, C. Michel Zwaan, Carolyn Grove, Richard Stone, Paul J Shami, Ioannis Mantzaris, Matthew Greenwood, Neerav Shukla, Branko Cuglievan, Yu Gu, Rebecca G Bagley, Kate Madigan, Soujanya Sunkaraneni, Huy Van Nguyen, Nicole McNeer, Eytan M. Stein
Journal: Blood (2023)
Pulmonary Embolism and the Impact of Concomitant Deep Vein Thrombosis on Outcomes Among Cancer Patients
Authors: Steven Callori, Robert D. McBane, Danielle T. Vlazny, Damon E. Houghton, David Froehling, David O. Hodge, Ana I. Casanegra, Waldemar E. Wysokinski
Journal: Blood (2023)
Phase 1/2 Dose-Escalation/Dose-Expansion Study of Anti-CD7 Allogeneic CAR-T Cells (WU-CART-007) in Relapsed or Refractory (R/R) T-Cell Acute Lymphoblastic Leukemia/ Lymphoblastic Lymphoma (T-ALL/LBL)
Authors: Armin Ghobadi, Ibrahim Aldoss, Shannon L. Maude, Deepa Bhojwani, Alan S. Wayne, Ashish Bajel, Rawan Faramand, Ryan J Mattison, Bhagirathbhai Dholaria, Michael P. Rettig, Ken Jacobs, Ouiam Bakkacha, John Muth, Angela Pannunzio, Brett Ramsey, Eileen McNulty, Matt L. Cooper, Jan Davidson-Moncada, John F. DiPersio
Journal: Blood (2023)
Outcomes after Bone Marrow Versus Peripheral Blood Haploidentical Hematopoietic Stem Cell Transplantation Using Post-Transplant Cyclophosphamide-Based Gvhd Prophylaxis
Authors: Muhammad Kashif Amin, Moazzam Shahzad, Joe S. Al-Ramahi, Shaun DeJarnette, Forat Lutfi, Nausheen Ahmed, Haitham Abdelhakim, Rajat Bansal, Leyla Shune, Al-Ola Abdallah, Anurag K. Singh, Sunil Abhyankar, Joseph P McGuirk, Muhammad Umair Mushtaq
Journal: Blood (2023)
Immune-Effector-Cell-Associated-Neurotoxicity-Syndrome (ICANS) Pathophysiology Is Mediated By Microglia TGF-β-Activated Kinase-1 Signaling
Authors: Janaki Manoja Vinnakota, Francesca Biavasco, Marius Schwabenland, Chintan Chhatbar, Rachael C Adams, Daniel Erny, Sandra Duquesne, Nadia El Khawanky, Henrike Salié, Dimitrios Athanassopoulos, Lukas Braun, Dominik Schmidt, Viktor Fetsch, Rebeka N. Javorniczky, Jenny N.H.G Ho, Reinhard Marks, Ralph Wäsch, Federico Simonetta, Geoffroy Andrieux, Dietmar Pfeifer, Gianni Monaco, Christian Capitini, Terry J. Fry, Thomas Blank, Bruce R Blazar, Eva-Maria Wagner Drouet, Matthias Theobald, Clemens Sommer, Matthias Stelljes, Christian Reicherts, Astrid Jeibmann, Jens Schittenhelm, Camelia-Maria Monoranu, Andreas Rosenwald, K. Martin Kortüm, Leo Rasche, Hermann Einsele, Philipp Tobias Meyer, Joachim Brumberg, Andreas Mackensen, Michael von Bergwelt-Baildon, Roland Coras, Nathalie L. Albert, Laura M. Bartos, Matthias Brendel, Adrien Holzgreve, Melanie Boerries, Crystal L. Mackall, Justus Duyster, Natalie Koehler, Felix Strübing, Bertram Bengsch, Marco Ruella, Marion Subklewe, Louisa von Baumgarten, Saar Gill, Marco Prinz, Robert Zeiser
Journal: Blood (2023)
Evaluating Effectiveness and Safety of Flumatinib for Chronic Phase Chronic Myeloid Leukemia in (CML-CP) without Optimal Response (Warning, Failure) to Imatinib or/and Dasatinib
Authors: Li Weiming, Yanli Zhang, Zhiwei Wu, Qin Wen, Qing Leng, Shuting Wu, Xiaodong Wang, Shiming Chen, Guolin Yuan, Sixuan Qian, Suning Chen, Daozi Jiang, Lianjun Diao, Zhenfang Xi, Hui Wu, Hui Sun, Lijie Yang, Hongjuan Wang, Xuefang Zhang, Yanli Xu, Xielan Zhao, Na Xu, Li Meng, Zunmin Zhu, Youfang Zhao, Meifang Su, Zhuangzhi Yang, Chuancai Liu, Danlei Han, Yu Hu
Journal: Blood (2023)
Real-World Treatment Patterns and Outcomes of Solitary Plasmacytoma in the United States: A National Cancer Database (NCDB) Analysis of Years 2004-2020
Authors: Ludovic Saba, Chieh-Lin Fu, Kaylee Sarna, Hong Liang, Barbara Geraldine Dominguez, John Greskovich, Chakra Pani Chaulagain
Journal: Blood (2023)
Results from the Cohort Expansion Stage of a Phase I Trial of Tinostamustine Monotherapy in Advanced Haematological Malignancies (NCT02576496): Findings from a Subset of Patients with Cutaneous T-Cell Lymphoma (CTCL)
Authors: Pier Luigi Zinzani, Franck Morschhauser, Tomas Janik, Nick Manamley, Kasia Hilgier, Anna Maria Sureda Balari
Journal: Blood (2023)
Planned Interim Safety Analysis of the Phase 3 Randomized Trial of Selinexor and Lenalidomide Versus Lenalidomide Maintenance Post Autologous Stem Cell Transplant for Patients with Newly Diagnosed Multiple Myeloma (ALLG MM23; Sealand)
Authors: Hang Quach, Masa Lasica, Michael Low, Peter Mollee, Hock Choong Lai, Nicole Wong Doo, Jay Hocking, Philip Campbell, Nicholas E. Murphy, M Hasib Sidiqi, David Routledge, Jessica Heenan, Noemi Horvath, Richard Eek, William E. P. Renwick, Douglas Stuart Lenton, Lauren J Child, Georgia McCaughan, Belinda E Butcher, Deepmala Mazumdar, Anna Kalff
Journal: Blood (2023)
Estimating Transfusion-Related Medical Costs and Associated Time Burden in Patients with Myelofibrosis: A Comparison of Momelotinib Vs Ruxolitinib Based on Simplify-1
Authors: Lucia Masarova, Tom Liu, Mirko Fillbrunn, Weilong Li, Gautam Sajeev, Sumati Rao, Boris Gorsh, James Signorovitch
Journal: Blood (2023)
Comparison of Outcomes of Hematopoietic Cell Transplantation (HCT) for Asymptomatic Patients with Sickle Cell Disease (SCD) and That of Propensity Matched Symptomatic Patients Undergoing HCT
Authors: Deeksha Katoch, Vineetha Nallagatla, Lakshmanan Krishnamurti
Journal: Blood (2023)
Patient (pt) Experiences of Receiving Idecabtagene Vicleucel (Ide-Cel, bb2121) Versus Standard (Std) Regimens for the Treatment (Tx) of Relapsed/Refractory Multiple Myeloma (RRMM) in the Randomized, Controlled KarMMa-3 Clinical Trial: Analysis of Longitudinal Qualitative Interviews
Authors: Paula Rodríguez Otero, Krina K. Patel, Noopur S. Raje, Olga Moshkovich, Heather Gerould, Jennifer Devlen, Devender Dhanda, Laurie Eliason, Mark Cook, Mihaela Popa-McKiver, Salomon Manier
Journal: Blood (2023)
Prevalence of Resistance-Associated Bruton Tyrosine Kinase (BTK) C481 Mutations By Prior Treatment Status Among Patients with Chronic Lymphocytic Leukemia (CLL)/Small Lymphocytic Lymphoma (SLL): A Real-World Observational Study
Authors: Jennifer Prescott, Torben Steiniche, Jeanette Bæhr Georgsen, Lene Hyldahl Ebbesen, Jens Kanstrup Kjær, Magdalena Snopekova, Laura H. Lorentsen, Tobias Ramm Eberlein, Robert Schou Pedersen, Mohammed Z.H. Farooqui, Bo Wei, Razvan Cristescu, Nicole Myer, Mette Kehlet, Francesco Annibale d'Amore
Journal: Blood (2023)
Two-Year Follow-up Results of C-CAR066, a Novel Anti-CD20 Chimeric Antigen Receptor Cell Therapy (CAR-T) in Relapsed or Refractory (r/r) Large B-Cell Lymphoma (LBCL) Patients after Failure of CD19 CAR-T Therapy
Authors: Ping Li, Wei Liu, Shiguang Ye, Lili Zhou, Judy Zhu, Jiaqi Huang, Jing Li, Shigui Zhu, Chengxiao Zheng, Kevin Zhu, Xin Yao, Hui Wan, Yihong Yao, Aibin Liang, Dehui Zou
Journal: Blood (2023)
Brentuximab Vedotin in Combination with Nivolumab in CD30+ Malignancies Refractory to Brentuximab Vedotin
Authors: Christina Poh, Ryan C Lynch, Edus H Warren, Chaitra S Ujjani, Stephen D Smith, Michi M Shinohara, Jonathan R Fromm, Xinyi Fan, Jenna M Voutsinas, Qian Wu, Laura Naylor, Heather Rasmussen, Ajay K Gopal
Journal: Blood (2023)
Efficacy and Safety Profile of CPX-351 in Secondary Acute Myeloid Leukemia (sAML): A Systematic Review
Authors: Ahmed Ibrahim, Muhammad Abdullah Yousaf, Mariam Ikram, Huma Khalid, . Anum, Omar A Safdar, Zain Anwer, Fatima Faraz, Mohammad Rehman, Muhammad Saad
Journal: Blood (2023)
A Multi-Center Retrospective Analysis of Outcomes Post Allogeneic Stem Cell Transplantation in AML Patients with TET2 Mutations: A Study on Behalf of the Global Committee and the Acute Leukemia Working Party of the European Society for Blood and Marrow Transplantation
Authors: Lin Li, Yishan Ye, Jacques-Emmanuel Galimard, Myriam Labopin, Depei Wu, Jia Chen, Nicolaus Kröger, Jakob Passweg, Urpu Salmenniemi, Maija Itäla-remes, Xavier Poiré, Matthias Eder, Johan Maertens, David Burns, Henrik Sengeloev, Gitte Olesen, Didier Blaise, Jürgen Finke, Alain Gadisseur, Ali Bazarbachi, Eolia Brissot, Arnon Nagler, Yi Luo, Jimin Shi, Fabio Ciceri, Mohamad Mohty, He Huang, Norbert Claude Gorin
Journal: Blood (2023)
A Phase 2 Study to Evaluate the Efficacy and Safety of Selinexor Monotherapy in Patients with JAK Inhibitor-Naïve Myelofibrosis and Moderate Thrombocytopenia (XPORT-MF-044)
Authors: Joseph M. Scandura, Aaron T. Gerds, Ellen K. Ritchie, Xulong Wang, Steve Kye, Raajit K. Rampal
Journal: Blood (2023)
Loss of Complement Factor I (Cfi) a Negative Regulator of Complement Cascade Activity Exacerbates JAK2V617F-Dependent Phenotype
Authors: Alissa Oakes, Dennis M Bonal, Zoe Creane, Hyunju Oh, Anna Dorota Chorzalska, Brooke Sadler, John L. Reagan, Rabin Niroula, Adam J Olszewski, Gabriel Haller, Stephen Donnelly, Patrycja M Dubielecka
Journal: Blood (2023)